The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Danilov D.S.

Klinika psikhiatrii im. S.S. Korsakova;
kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Effect of side-effects and complications caused by atypical neuroleptics on the effectiveness of therapy in patients with schizophrenia

Authors:

Danilov D.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(3): 48‑55

Read: 11338 times

Download PDF (RU)
Contact the author
Table of contents

EFFECT OF SIDE-EFFECTS AND COMPLICATIONS CAUSED BY ATYPICAL NEUROLEPTICS ON THE EFFECTIVENESS OF THERAPY IN PATIENTS WITH SCHIZOPHRENIA
EFFECT OF SIDE-EFFECTS AND COMPLICATIONS CAUSED BY ATYPICAL NEUROLEPTICS ON THE EFFECTIVENESS OF THERAPY IN PATIENTS WITH SCHIZOPHRENIA

To cite this article:

Danilov DS. Effect of side-effects and complications caused by atypical neuroleptics on the effectiveness of therapy in patients with schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(3):48‑55. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Stress and sleep: Neurobiological aspe­cts and modern options of inso­mnia therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5-2):14-21
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Analysis of cognitive status in patients with different noso­logies and clinical variants of very late mani­festing schi­zophreniform psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):88-93
Features of perioperative period in patients with cardiovascular-kidney-metabolic syndrome. Russian Journal of Anesthesiology and Reanimatology. 2025;(2):26-33
Characteristics, treatment features and in-hospital mortality of patients with myocardial infa­rction over 75 years old in Russia acco­rding to the REGION-IM regi­stry. Russian Cardiology Bulletin. 2025;(1):22-38
Pharmacological treatment and prevention of ischemia-reperfusion syndrome in percutaneous coro­nary inte­rvention. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):191-200
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Complexity index of microsurgical treatment of unru­ptured cere­bral aneurysms. Burdenko's Journal of Neurosurgery. 2025;(3):28-41
Perioperative complications in surgery for craniosynostosis in children: a systematic review and meta-analysis. Burdenko's Journal of Neurosurgery. 2025;(3):114-121
Postoperative peri­tonitis: epidemiology, diagnosis, surgical treatment and prognosis. Piro­gov Russian Journal of Surgery. 2025;(6):104-111
Abstract:

434 patients were treated with clozapine, risperidone, olanzapine, quetiapine or typical neuroleptics. Main types of undesirable effects (side-effects and complications) that affected the effectiveness of treatment were singled out. It has been shown that the reduction of effectiveness may lead to the revision of treatment plan on life-saving indications or due to ethical considerations, the maintenance of therapeutic collaboration or the negative attitude of relatives to treatment. The data obtained suggest a different effect of side-effects on the effectiveness of treatment with atypical and typical antipsychotic drugs.

Keywords:

schizophrenia
treatment
antipsychotic drugs
typical and atypical neuroleptics
side-effects
complications

Authors:

Danilov D.S.

Klinika psikhiatrii im. S.S. Korsakova;
kafedra psikhiatrii i meditsinskoĭ psikhologii Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Close metadata

References:

  1. Avrutskii G.Ya., Gurovich I.Ya., Gromova V.V. Farmakoterapiya psikhicheskikh zabolevanii. M: Meditsina 1974; 472.
  2. Avrutskii G.Ya., Neduva A.A. Lechenie psikhicheski bol'nykh. M: Meditsina 1988; 528.
  3. Burlakov A.V. Aspekty effektivnosti i bezopasnosti primeneniya antipsikhotikov u bol'nykh shizofreniei s soputstvuyushchei somaticheskoi patologiei. Simpozium «Farmakoterapiya psikhozov i rasstroistv nastroeniya s soputstvuyushchei somaticheskoi patologiei». Materialy. Psikhicheskie rasstroistva v obshchei meditsine 2006; 1: 2: 40-42.
  4. Gorobets L.N. Neiroendokrinnye disfunktsii u bol'nykh shizofreniei i shizoaffektivnym rasstroistvom v usloviyakh sovremennoi antipsikhoticheskoi terapii (kliniko-biokhimicheskoe issledovanie): Avtoref. dis. ... d-ra med. nauk. M 2007.
  5. Danilov D.S. Vliyanie podderzhivayushchei psikhofarmakoterapii na kachestvo zhizni bol'nykh shizofreniei s pristupoobraznym techeniem: Dis. ... kand. med. nauk. M 2005; 151.
  6. Danilov D.S. Prediktory nonkomplaensa i differentsirovannyi podkhod k optimizatsii terapevticheskogo sotrudnichestva bol'nykh shizofreniei. Psikhiat i psikhofarmakoter 2008; 10: 3: 16-22.
  7. Danilov D.S., Khokhlova V.A., Lapina I.A., Danilova L.M. Somaticheskie pobochnye effekty sovremennoi antipsikhoticheskoi terapii: mekhanizmy razvitiya, klinicheskie proyavleniya, rol' v ogranichenii effektivnosti lecheniya shizofrenii i metody korrektsii. Ros med vesti 2008; 13: 3: 23-33.
  8. Drobizhev M.Yu., Dobrovol'skii A.V., Doletskii A.A. Kardiologicheskie i psikhopatologicheskie aspekty bezopasnosti kombinirovannoi kardio- i psikhotropnoi terapii. Psikhiat i psikhofarmakoter 2005; 3: 7: 132-137.
  9. Malin D.I., Kozyrev V.N., Ravilov R.S., Spivak B. Zlokachestvennyi neirolepticheskii sindrom (epidemiologiya, faktory riska, klinika, diagnostika, patogenez, terapiya). Psikhiat i psikhofarmakoter 2000; 2: 5: 138-141.
  10. Morozova V.D. Osobennosti kliniki shizofrenii, sochetayushcheisya s tserebral'noi sosudistoi patologiei. M 1987; 24.
  11. Mosolov S.N. Polveka antipsikhoticheskoi farmakoterapii: osnovnye itogi i novye rubezhi. V kn.: Dofaminovaya teoriya patogeneza shizofrenii. Rukovodstvo dlya vrachei. Per. s angl. Pod red. S.N. Mosolova. London - New York 2004; 14-49.
  12. Smulevich A.B. Shkala otsenki pobochnykh effektov UKU. V kn.: Depressii v obshchei meditsine. M: MIA 2001; 207-222.
  13. Chitaya N.N. Neirolepticheskii sindrom pri ispol'zovanii tipichnykh i atipichnykh neiroleptikov: Avtoref. dis. ... kand. med. nauk. M 2009; 22.
  14. Shternberg E.Ya. Osobennosti pobochnogo deistviya psikhotropnykh sredstv v pozdnem vozraste. V kn.: Vserossiiskii s''ezd nevropatologov i psikhiatrov, 2-i. M 1967; 552-553.
  15. Abdelmawla N., Mitchel A.J. Sudden cardiac death and antipsychotics. Part 1: Risk factors and mechanisms. Advances in Psychiat Treatment 2006; 12: 1: 35-44.
  16. Alvarez E., Ciudad A., Olivares J. et al. A randomized, 1-year follow-up study of olanzapine and risperidone in the treatment of negative symptoms in outpatients with schizophrenia. J Clin Psychopharmacol 2006; 26: 3: 238-249.
  17. Flanagan R.J., Dunk L. Haematological toxicity of drugs used in psychiatry. Human Psychopharmacol 2008; Suppl 1: 27-41.
  18. Haddad P.M. Antipsychotics and diabetes: review of non-prospective data. Br J Psychiat 2004; Suppl 47: 80-86.
  19. Leon J., Susce M.T., Johnson M. et al. A clinical study of the association of antipsychotics with hyperlipidemia. Schizophr Res 2007; 92: 1-3: 95-102.
  20. Lingjaerde O., Ahlfors U.G., Bech P. The UKU side-effect rating scale. A new comprehensive rating scale for psychotropic drugs and cross-sectional study of side-effects in neuroleptic treated patients. Acta Psychiat Scandinavica 1987; 334: Suppl: 1-100.
  21. McEvoy J.P., Lieberman J.A., Perkins D.O. et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiat 2007; 164: 1050-1060.
  22. Olfson M., Mechanic D., Hansell S. et al. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiat Services 2000; 51: 2: 216-222.
  23. Osby U., Correia N., Brandt L. et al. Mortality and causes of death in schizophrenia in Stockholm county, Sweden. Schizophr Res 2000; 45: 1-2: 21-28.
  24. Perkins D.O. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiat 2002; 63: 12: 1121-1128.
  25. Stöllberger C., Huber J.O., Finsterer J. Antipsychotic drugs and QT prolongation. Int Clin Psychopharmacol 2005; 20: 5: 243-251.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.